The role of vagal afferent nerves in chronic obstructive pulmonary disease

Proceedings of the American Thoracic Society

Volumn 2, Issue 4, 2005, Pages 355-360

  Undem, Bradley J ^a,b   Kollarik, Marian ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Bronchopulmonary C fibers; Nociceptors; Stretch sensitive mechanosensors; Vagal dysregulation

Indexed keywords

AUTONOMIC NERVE; BRONCHUS MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; COUGHING; LUNG DISEASE; MUCUS SECRETION; NOCICEPTION; SMOOTH MUSCLE CONTRACTION; VAGUS NERVE;

ANIMALS; BRONCHI; COUGH; DYSPNEA; HUMANS; LUNG; NEURONS, AFFERENT; NOCICEPTORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFLEX; VAGUS NERVE;

EID: 28244483892     PISSN: 15463222     EISSN: 15463222     Source Type: Journal    
DOI: 10.1513/pats.200504-033SR     Document Type: Conference Paper

References (54)

1. Adriaensen D, Brouns I, Van Genechten J, Timmermans JP. Functional morphology of pulmonary neuroepithelial bodies: extremely complex airway receptors. Anal Rec 2003;270A:25-40.
2. Sant'Ambrogio G, Widdicombe J. Reflexes from airway rapidly adapting receptors. Respir Physiol 2001;125:33-45.
3. Sherrington CS. Qualitative differences of spinal reflex corresponding with qualitative difference of cutaneous stimulus. J Physiol 1903;30:39-46.
4. Sherrington SC. The integrative action of the nervous system. New Haven, CT: Yale University Press; 1906.
5. Riccio MM, Kummer W, Biglari B, Myers AC, Undem BJ. Interganglionic segregation of distinct vagal afferent fibre phenotypes in guineapig airways. J Physiol 1996;496:521-530.
6. Canning BJ, Mazzone SB, Meeker SN, Mori N, Reynolds SM, Undem BJ. Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guinea-pigs. J Physiol 2004;557:543-558.
7. McAlexander MA, Myers AC, Undem BJ. Adaptation of guinea-pig vagal airway afferent neurones to mechanical stimulation. J Physiol 1999;521:239-247.
8. Kollarik M, Undem BJ. Mechanisms of acid-induced activation of airway afferent nerve fibres in guinea-pig. J Physiol 2002;543:591-600.
9. Agostoni E, Chinnock JE, De Burgh Daly M, Murray JG. Functional and histological studies of the vagus nerve and its branches to the heart, lungs and abdominal viscera in the cat. J Physiol 1957;135:182-205.
10. Lee LY, Pisarri TE. Afferent properties and reflex functions of bronchopulmonary C-fibers. Respir Physiol 2001;125:47-65.
11. Coleridge JC, Coleridge HM. Afferent vagal C fibre innervation of the lungs and airways and its functional significance. Rev Physiol Biochem Pharmacol 1984;99:1-110.
12. Paintal AS. Some recent advances in studies on J receptors. Adv Exp Med Biol 1995;381:15-25.
13. Undem BJ, Chuaychoo B, Lee MG, Weinreich D, Myers AC, Kollarik M. Subtypes of vagal afferent C-fibres in guinea-pig lungs. J Physiol 2004;556:905-917.
14. Baker CV, Bronner-Fraser M. Vertebrate cranial placodes I. Embryonic induction. Dev Biol 2001;232:1-61.
15. Chuaychoo B, Lee MG, Kollarik M, Undem BJ. Effect of 5-hydroxytryptamine on vagal C-fiber subtypes in guinea pig lungs. Pulm Pharmacol Ther 2005;18:269-276.
16. Coleridge HM, Coleridge JC. Pulmonary reflexes: neural mechanisms of pulmonary defense. Annu Rev Physiol 1994;56:69-91.
17. Ma A, Bravo M, Kappagoda CT. Responses of bronchial C-fiber afferents of the rabbit to changes in lung compliance. Respir Physiol Neurobiol 2003;138:155-163.
18. Green JF, Schertel ER, Coleridge HM, Coleridge JC. Effect of pulmonary arterial PCO2 on slowly adapting pulmonary stretch receptors. J Appl Physiol 1986;60:2048-2055.
19. Carr MJ, Undem BJ. Pharmacology of vagal afferent nerve activity in guinea pig airways. Pulm Pharmacol Ther 2003;16:45-52.
20. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor, a heat-activated ion channel in the pain pathway. Nature 1997;389:816-824.
21. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, Cho S, Min KH, Suh YG, Kim D, et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 2000;97:6155-6160.
22. Carr MJ, Kollarik M, Meeker SN, Undem BJ. A role for TRPV1 in bradykinin-induced excitation of vagal airway afferent nerve terminals. J Pharmacol Exp Ther 2003;304:1275-1279.
23. Shin J, Cho H, Hwang SO, Jung J, Shin CY, Lee SY, Kim SH, Lee MG, Choi YH, Kim J, et al. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 2002;99:10150-10155.
24. Kollarik M, Undem BJ. Activation of bronchopulmonary vagal afferent nerves with bradykinin, acid and vanilloid receptor agonists in wild-type and TRPV1-/- mice. J Physiol 2004;555:115-123.
25. Hong JL, Ho CY, Kwong K, Lee LY. Activation of pulmonary C fibres by adenosine in anaesthetized rats: role of adenosine Al receptors. J Physiol 1998;508:109-118.
26. Lee LY, Kwong K, Lin YS, Gu Q. Hypersensitivity of bronchopulmonary C-fibers induced by airway mucosal inflammation: cellular mechanisms. Pulm Pharmacol Ther 2002;15:199-204.
27. Carr MJ, Hunter DD, Jacoby DB, Undem BJ. Expression of tachykinins in nonnociceptive vagal afferent neurons during respiratory viral infection in guinea pigs. Am J Respir Crit Care Med 2002;165:1071-1075.
28. Myers AC, Kajekar R, Undem BJ. Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am J Physiol Lung Cell Mol Physiol 2002;282:L775-L781.
29. Hunter DD, Myers AC, Undem BJ. Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons. Am J Respir Crit Care Med 2000;161:1985-1990.
30. Neumann S, Doubell TP, Leslie T, Woolf CJ. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996;384:360-364.
31. Chen C-Y, Bonham AC, Plopper CG, Joad JP. Neuroplasticity in nucleus tractus solitarius neurons after episodic ozone exposure in infant primates. J Appl Physiol 2003;94:819-827.
32. Ren K, Dubner R. Central nervous system plasticity and persistent pain. J Orofac Pain 1999;13:155-163 (Discussion: 164-171).
33. Baker-Herman TL, Fuller DD, Bavis RW, Zabka AG, Golder FJ, Doperalski NJ, Johnson RA, Watters JJ, Mitchell GS. BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nat Neurosci 2004;7:48-55.
34. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003;290:2301-2312.
35. Canning BJ, Fischer A. Neural regulation of airway smooth muscle tone. Respir Physiol 2001;125:113-127.
36. Rogers DF. Motor control of airway goblet cells and glands. Respir Physiol 2000;125:129-144.
37. Mazzone SB, Canning BJ. Synergistic interactions between airway afferent nerve subtypes mediating reflex bronchospasm in guinea pigs. Am J Physiol Regul Integr Comp Physiol 2002;283:R86-R98.
38. Kesler BS, Canning BJ. Regulation of baseline cholinergic tone in guinea-pig airway smooth muscle. J Physiol 1999;518:843-855.
39. Mills JE, Sellick H, Widdicombe JG. Activity of lung irritant receptors in pulmonary microembolism, anaphylaxis and drug-induced bronchoconstrictions. J Physiol 1969;203:337-357.
40. Canning BJ, Undem BJ. Evidence that distinct neural pathways mediate parasympathetic contractions and relaxations of guinea-pig trachealis. J Physiol 1993;471:25-40.
41. Irwin RS, French CT, Fletcher KE. Quality of life in coughers. Pulm Pharmacol Ther 2002;15:283-286.
42. Doherty MJ, Mister R, Pearson MG, Calverley PMA. Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease. Thorax 2000;55:643-649.
43. Wong CH, Morice AH. Cough threshold in patients with chronic obstructive pulmonary disease. Thorax 1999;54:62-64.
44. Butler JE, Anand A, Crawford MR, Glanville AR, McKenzie DK, Paintal AS, Taylor JL, Gandevia SC. Changes in respiratory sensations induced by lobeline after human bilateral lung transplantation. J Physiol 2001;534:583-593.
45. Simon PM, Schwartzstein RM, Weiss JW, Fencl V, Teghtsoonian M, Weinberger SE. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990;142:1009-1014.
46. Cherniack NS, Altose MD. Mechanisms of dyspnea. Clin Chest Med 1987;8:207-214.
47. Schwartzstein RM, Manning HL, Weiss JW, Weinberger SE. Dyspnea: a sensory experience. Lung 1990;168:185-199.
48. Stark RD, Russel NJW, Clova Stark A. Dyspnea: a possible target for pharmacological intervention. In: Adams 1, Guz A, editors. Respiratory sensations. New York: Marcel Dekker, Inc.; 1996. pp. 341-363.
49. Bradley GW, Hale T, Pimble J, Rowlandson R, Noble MIM. Effect of vagotomy on the breathing pattern and exercise ability in emphysematous patients. Clin Sci 1982;62:311-319.
50. Nishino T, Ide T, Sudo T, Sato J. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am J Respir Crit Care Med 2000;161:1963-1967.
51. Ong K-C, Kor A-C, Chong W-F, Earnest A, Wang Y-T. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;169:1028-1033.
52. 2 inhalation increases the sensation of dyspnea during exercise. Am Rev Respir Dis 1992;145:1346-1349.
53. Burki NK, Dale WJ, Lee L-Y. Intravenous adenosine and dyspnea in humans. J Appl Physiol 2005;98:180-185.
54. Canning BJ. Interactions between vagal afferent nerve subtypes mediating cough. Pulm Pharmacol Ther 2002;15:187-192.